Please use this identifier to cite or link to this item:
Title: MYC is a critical target of FBXW7
Author: Sato, Mai
Rodriguez Barrueco, Ruth
Yu, Jiyang
Do, Catherine
Silva, Jose M.
Gautier, Jean
Keywords: Càncer
Issue Date: 26-Dec-2014
Publisher: Impact Journals
Abstract: MYC deregulation is a driver of many human cancers. Altering the balance of MYC protein levels at the level of transcription, protein stability, or turnover is sufficient to transform cells to a tumorigenic phenotype. While direct targeting of MYC is difficult, specific genetic vulnerabilities of MYC-deregulated cells could be exploited to selectively inhibit their growth. Using a genome-wide shRNA screen, we identified 78 candidate genes, which are required for survival of human mammary epithelial cells with elevated MYC levels. Among the candidates, we validated and characterized FBXW7, a component of the SCF-like ubiquitin ligase complex that targets MYC for proteasomal degradation. Down-regulation of FBXW7 leads to synergistic accumulation of cellular and active chromatin-bound MYC, while protein levels of other FBXW7 targets appear unaffected. Over a four-week time course, continuous FBXW7 down-regulation and MYC activation together cause an accumulation of cells in S-phase and G2/M-phase of the cell cycle. Under these conditions, we also observe elevated chromatin-bound levels of CDC45, suggesting increased DNA replication stress. Consistent with these results, FBXW7 down-regulation alone decreases the survival of T47D breast cancer cells. These results establish that FBXW7 down-regulation is synthetic lethal with MYC, and that MYC is a critical target of FBXW7 in breast epithelial cells.
Note: Reproducció del document publicat a:
It is part of: Oncotarget, 2014, vol. 6, num. 5, p. 3292-3305
Related resource:
ISSN: 1949-2553
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
694978.pdf1.76 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons